Anaemia correction - Does the mode of dialysis matter?

Nephrology Dialysis Transplantation

Volumn 15, Issue 9, 2000, Pages 1278-1280

  Eckardt, Kai Uwe ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; TOXIN;

ANEMIA; BIOCOMPATIBILITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; DIALYSIS MEMBRANE; DRUG RESPONSE; EDITORIAL; ERYTHROPOIESIS; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; UREMIA;

EID: 0033833234     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.9.1278     Document Type: Editorial

References (23)

1. Effect of high-flux dialysis on the anaemia of hemodialysis patients
2. Erythropoietin: Oxygen-dependent control of erythropoiesis and its failure in renal disease
3. The rate and control of baseline red cell production in hematologically stable patients with uremia
4. Single dose kinetics of recombinant human erythropoietin (rhEPO) after i.v., s.c. and i.p. administration: Preliminary results
5. Role of excretory graft function for erythropoietin formation after renal transplantation
6. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
7. Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity
8. The anemia of end-stage renal disease: Hematopoietic progenitor cell response
9. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure
10. Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis
11. Effect of parathyroid hormone on erythropoiesis
12. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis
13. Anemia and secondary hyperparathyroidism
14. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis
15. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects
16. Disorders of red cell production in uremia
17. Anemia of the regular hemodialysis patient and its treatment
18. Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA registry
19. Fluid state and blood pressure control in patients treated with long and short dialysis
20. Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis
21. Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease
22. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
23. Efficacy of recombinant human erythropoeitin in the critically ill patient: A randomized, double-blind, placebo-controlled trial